On July 21, 2023, the national launch conference for Epicon A® scleral lens, the first approved scleral lens in China, was successfully held in the beautiful northern ice city of Harbin!
1 national top eye watch expert
Three fantastic and unparalleled Epicon A® Theme report on scleral endoscopy
400+ophthalmic colleagues stopped at the scene to observe
Using a mirror as a boat, helping the eyes clear and bright
〖Professor Shi Weiyun's Opening Speech〗
At the beginning of the meeting, Professor Shi Weiyun, Dean of the Affiliated Eye Hospital of Shandong First Medical University and Head of the National Corneal Disease Group, gave a welcome speech, "I would like to congratulate on the official launch of the first scleral lens approved in China, Epicon A®. It will fill the gap in the treatment of complex ocular surface diseases in China. Especially for diseases such as keratoconus, irregular astigmatism, various refractive errors, moderate to severe dry eye, it has opened up a new way of diagnosis and treatment," and expressed the expectation that Epicon A® would help patients obtain a comfortable, clear, and lasting visual experience.
〖Professor Gao Hua and Professor Zhang Hong presided over the event〗
〖Tony Capitano Speech by the General Manager〗
Tony Capitano, General Manager of Capricornia Contact Lens Limited in Australia, gave a speech. Capricornia Contact Lens Co., Ltd. has been focusing on contact lenses for 38 years, specializing in lens design and research and development. It has collaborated with multiple universities in Australia, including the University of New South Wales, to develop contact lenses. Lens design has won international awards multiple times and has published a large number of influential papers. In 1994, the company developed the first scleral lens. Epicon A® The development of scleral lenses is the result of thousands of lens fitting and analysis, designed specifically for Asians. On July 19th, Capricornia and Raytec Biotechnology officially signed a joint venture agreement in Wenjiang, Chengdu, to build a world-class and state-of-the-art production base, which will be fully operational in 2025. Subsequently, they will gradually introduce Australian visual products to China. And express their admiration for Epicon A® Congratulations on the first approved scleral lens in China!
〖Epicon A® Launch Ceremony for Listing〗
With the joint participation of Professor Shi Weiyun, Professor Liu Guoguo, Professor Hong Jing, Director Huang Yibin, Professor Chen Wei, Professor Jieying, Professor Yuan Jin, General Manager Tony, and General Manager Xu Hao of Raytec Biology, Epicon A® The listing ceremony is officially launched!
〖Epicon A® Scleroscope keynote speech segment〗
Three top national eye watch experts have brought us three high-quality Epicon A® Theme speech on scleral endoscopy:
Professor Chen Wei from the Eye and Vision Hospital of Wenzhou Medical University reported on the real-world research results of Epicon A® scleral lens in Hainan: Epicon A® scleral lens has good safety for patients with keratoconus, irregular corneal astigmatism, and moderate to severe dry eye (combined with refractive error), high comfort in wearing, and effectively improves patients' ocular surface conditions, with a one-time successful fitting rate of up to 71%.
Professor Jie Ying from Beijing Tongren Hospital affiliated to Capital Medical University delivered a keynote speech on the topic of scleral lens treatment for moderate to severe dry eye. The scleral lens has excellent improvement effects on moderate to severe dry eye caused by various reasons, and shared clinical applications and fitting cases of Epicon A® scleral lens.
Professor Yuan Jin from the Zhongshan Ophthalmic Center of Sun Yat-sen University shared the application of scleral lenses in the correction of irregular astigmatism. Scleral lenses can not only improve patients' vision but also effectively reduce high-order aberrations in the eyes of various patients with irregular astigmatism, improving their visual quality. Compared to corneal RGP, patients' tolerance and compliance with scleral lenses are better.
Director Huang Yibin from the Chinese Journal of Ophthalmology of the Chinese Medical Association, Professor Liu Zuguo from the Xiamen University Eye Research Institute, and Professor Hong Jing from Peking University Third Hospital expressed their insightful views on the above presentations.
〖Summary of Professor Zhou Xingtao's Conference〗
Professor Zhou Xingtao from the Eye, ENT Hospital of Fudan University delivered a wonderful summary of the conference. Professor Zhou affirmed the therapeutic effectiveness of scleral lenses and summarized the characteristics of Epicon A® scleral lenses: Boston XO2® material with ultra-high oxygen permeability Dk141; three-zone independent design, quadrant adjustment; diversified lens design, suitable for all ocular surfaces; simple fitting, short learning curve, with a one-time fitting success rate of up to 71%; 30 years of fitting technology accumulation, and over 50,000 successful scleral lens records. He also looked forward to Epicon A® scleral lenses combining the multi-disciplinary advantages of Chinese ophthalmology clinics to transform product technology into a clinical tool, helping patients with keratoconus, corneal irregular astigmatism, moderate to severe dry eye, and various refractive errors in China achieve clear, comfortable, and sustained visual experiences.